Roberta Di Blasi

16PUBLICATIONS
184CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Federico Erbella, Emmanuel Bachy, Guillaume Cartron

|Aug 08, 2025
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study.

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco

|Jun 24, 2025
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T.

Eugenio Galli, Roberta Di Blasi, Ilaria Pansini

|May 01, 2025
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

Pierre Stephan, Roberta Di Blasi, Louise Roulin

|Jan 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study.

Xavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros

|Apr 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia.

Eric Durot, Damien Roos-Weil, Adrien Chauchet

Pageof 3

Frequent Collaborators

7 joint publications

Emmanuel Bachy

5 joint publications

Roch Houot

5 joint publications

Steven Le Gouill

5 joint publications

François-Xavier Gros